BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10709441)

  • 1. [Renal tolerance of cidofovir].
    Bagnis C; Izzdine H; Deray G
    Therapie; 1999; 54(6):689-91. PubMed ID: 10709441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe irreversible proximal renal tubular acidosis and azotaemia secondary to cidofovir.
    Kay TD; Hogan PG; McLeod SE; Johnson DW
    Nephron; 2000 Nov; 86(3):348-9. PubMed ID: 11096296
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
    Wolf DL; Rodríguez CA; Mucci M; Ingrosso A; Duncan BA; Nickens DJ
    J Clin Pharmacol; 2003 Jan; 43(1):43-51. PubMed ID: 12520627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical use of cidofovir induced acute renal failure.
    Bienvenu B; Martinez F; Devergie A; Rybojad M; Rivet J; Bellenger P; Morel P; Gluckman E; Lebbé C
    Transplantation; 2002 Feb; 73(4):661-2. PubMed ID: 11889450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular cell apoptosis and cidofovir-induced acute renal failure.
    Ortiz A; Justo P; Sanz A; Melero R; Caramelo C; Guerrero MF; Strutz F; Müller G; Barat A; Egido J
    Antivir Ther; 2005; 10(1):185-90. PubMed ID: 15751777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys.
    Lacy SA; Hitchcock MJ; Lee WA; Tellier P; Cundy KC
    Toxicol Sci; 1998 Aug; 44(2):97-106. PubMed ID: 9742650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal failure in a lung transplant patient after therapy with cidofovir.
    Zedtwitz-Liebenstein K; Presterl E; Deviatko E; Graninger W
    Transpl Int; 2001 Dec; 14(6):445-6. PubMed ID: 11793044
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
    Cundy KC
    Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits.
    Cundy KC; Li ZH; Lee WA
    Drug Metab Dispos; 1996 Mar; 24(3):315-21. PubMed ID: 8820422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nursing considerations in the use of cidofovir for CMV retinitis in patients with AIDS: report of a roundtable meeting.
    Martin MA; Kane C
    J Assoc Nurses AIDS Care; 1997; 8(5):66-74. PubMed ID: 9298471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cidofovir ocular toxicity is related to previous ocular history.
    Labetoulle M; Goujard C; Frau E; Offret H; Delfraissy JF; Gasnault J
    AIDS; 2000 Mar; 14(5):622-3. PubMed ID: 10780729
    [No Abstract]   [Full Text] [Related]  

  • 13. Cidofovir-induced end-stage renal failure.
    Meier P; Dautheville-Guibal S; Ronco PM; Rossert J
    Nephrol Dial Transplant; 2002 Jan; 17(1):148-9. PubMed ID: 11773481
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases.
    Peyrière H; Reynes J; Rouanet I; Daniel N; de Boever CM; Mauboussin JM; Leray H; Moachon L; Vincent D; Salmon-Céron D
    J Acquir Immune Defic Syndr; 2004 Mar; 35(3):269-73. PubMed ID: 15076241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral drug-induced nephrotoxicity.
    Izzedine H; Launay-Vacher V; Deray G
    Am J Kidney Dis; 2005 May; 45(5):804-17. PubMed ID: 15861345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cidofovir in pediatric solid organ transplant recipients: University of Nebraska experience.
    Florescu DF; Chambers HE; Qiu F; Keck MA; Mercer DF; Morris MC; Florescu MC
    Pediatr Infect Dis J; 2015 Jan; 34(1):47-51. PubMed ID: 25010830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1.
    Ho ES; Lin DC; Mendel DB; Cihlar T
    J Am Soc Nephrol; 2000 Mar; 11(3):383-393. PubMed ID: 10703662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cidofovir-induced end-stage renal failure.
    Vandercam B; Moreau M; Goffin E; Marot JC; Cosyns JP; Jadoul M
    Clin Infect Dis; 1999 Oct; 29(4):948-9. PubMed ID: 10589927
    [No Abstract]   [Full Text] [Related]  

  • 19. Tenofovir-associated renal and bone toxicity.
    Woodward CL; Hall AM; Williams IG; Madge S; Copas A; Nair D; Edwards SG; Johnson MA; Connolly JO
    HIV Med; 2009 Sep; 10(8):482-7. PubMed ID: 19459988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.
    Cihlar T; Ho ES; Lin DC; Mulato AS
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):641-8. PubMed ID: 11563082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.